Must Reads: Societe Generale: Poised For A Record Year

At x0.4 Price to Book, Societe Generale's valuation makes little sense - especially considering the attractive interest

Must Reads Societe Generale: Poised For A Record Year  At x0.4 Price to Book, Societe Generale's valuation makes little sense - especially considering the attractive interest rate environment. With the ECB... Continue Reading FEATURED: 50% off your first year of Premium Earnings season can spark serious volatility. Now's the time to protect your portfolio - and find compelling opportunities. Seeking Alpha Premium gives you in-depth, timely insights into almost every stock out there. Now 50% off your first year! Go Premium Now Sanofi: Increasing Our Long Position Sanofi delivered a good set of numbers. Dupixent is well on track with our estimates. However, the French pharma giant anticipates more moderate growt... Continue Reading EDAP: Potential Crossover Of HIFU To Endometriosis Additional Inflection Points EDAP continues to rate higher in 2023. Positive phase 2 data investigating HIFU in rectal endometriosis adds another inflection point for investors to... Continue Reading BNP Paribas' Earnings Report Could Surprise Many BNP Paribas is set to release its quarterly earnings report on Tuesday, the 7th of February. Key variables suggest BNP Paribas' Q4 report could surpri... Continue Reading L'Oréal: Expecting Good Q4 2022 Results I expect LRLCF to report good results in 4Q22, driven by outperformance in the US and Europe, but China may be a drag. I believe consensus estimates f... Continue Reading Download the Seeking Alpha App! Like Must Reads? Try our other newsletters as well. This email was sent to you because you signed up to receive Must Reads. If you do not want to receive Must Reads emails, click here to unsubscribe. Sent by Seeking Alpha, 234 5th Ave, 5th floor, New York, NY 10001